Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
Top Cited Papers
Open Access
- 1 July 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (1), 296-303
- https://doi.org/10.1182/blood-2005-01-0034
Abstract
Two oncogenic pathways have been hypothesized for multiple myeloma (MM) and premalignant monoclonal gammopathy of undetermined significance (MGUS) tumors: a nonKeywords
This publication has 41 references indexed in Scilit:
- Genetics and Cytogenetics of Multiple MyelomaCancer Research, 2004
- Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion ReceptorsThe Journal of Experimental Medicine, 2004
- Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell developmentBlood, 2003
- Development of mice expressing a single D-type cyclinGenes & Development, 2002
- Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myelomaLeukemia, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosisLeukemia, 2002
- Chromosome translocations in multiple myelomaOncogene, 2001
- p16 INK4a andp15INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significanceBlood, 2001
- Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40Journal of Biological Chemistry, 2000